# The Effect Of Aspirin On Survival in Lung Cancer

> **NCT01058902** · PHASE3 · WITHDRAWN · sponsor: **Liverpool Heart and Chest Hospital NHS Foundation Trust**

## Conditions studied

- Non Small Cell Lung Cancer
- Survival
- Aspirin

## Interventions

- **DRUG:** Aspirin 75 mg
- **OTHER:** no aspirin

## Key facts

- **NCT ID:** NCT01058902
- **Lead sponsor:** Liverpool Heart and Chest Hospital NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08
- **Primary completion:** 2015-08
- **Final completion:** 2020-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** failed to achive funding
- **Last updated:** 2016-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01058902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01058902, "The Effect Of Aspirin On Survival in Lung Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01058902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*